98 related articles for article (PubMed ID: 24706695)
1. Development of an active site peptide analog of α-fetoprotein that prevents breast cancer.
Jacobson HI; Andersen TT; Bennett JA
Cancer Prev Res (Phila); 2014 Jun; 7(6):565-73. PubMed ID: 24706695
[TBL] [Abstract][Full Text] [Related]
2. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
4. AFPep: an anti-breast cancer peptide that is orally active.
Bennett JA; DeFreest L; Anaka I; Saadati H; Balulad S; Jacobson HI; Andersen TT
Breast Cancer Res Treat; 2006 Jul; 98(2):133-41. PubMed ID: 16538538
[TBL] [Abstract][Full Text] [Related]
5. AFPep, a novel drug for the prevention and treatment of breast cancer, does not disrupt the estrous cycle or fertility in rats.
Tower AM; Trinward A; Lee K; Joseph L; Jacobson HI; Bennett JA; Andersen TT
Oncol Rep; 2009 Jul; 22(1):49-56. PubMed ID: 19513504
[TBL] [Abstract][Full Text] [Related]
6. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy.
Jacobson HI; Lemanski N; Agarwal A; Narendran A; Turner KE; Bennett JA; Andersen TT
Cancer Prev Res (Phila); 2010 Feb; 3(2):212-20. PubMed ID: 19934340
[TBL] [Abstract][Full Text] [Related]
7. Structural analysis of α-fetoprotein (AFP)-like peptides with anti-breast-cancer properties.
Temelso B; Alser KA; Gauthier A; Palmer AK; Shields GC
J Phys Chem B; 2014 May; 118(17):4514-26. PubMed ID: 24702603
[TBL] [Abstract][Full Text] [Related]
8. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
9. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
10. Isolation and structural and functional characterization of two stable peptic fragments of human alpha-fetoprotein.
Dudich I; Tokhtamysheva N; Semenkova L; Dudich E; Hellman J; Korpela T
Biochemistry; 1999 Aug; 38(32):10406-14. PubMed ID: 10441135
[TBL] [Abstract][Full Text] [Related]
11. Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.
Mizejewski GJ; Mirowski M; Garnuszek P; Maurin M; Cohen BD; Poiesz BJ; Posypanova GA; Makarov VA; Severin ES; Severin SE
J Drug Target; 2010 Sep; 18(8):575-88. PubMed ID: 20151941
[TBL] [Abstract][Full Text] [Related]
12. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk.
Richardson BE; Peck JD; Wormuth JK
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1349-55. PubMed ID: 11142421
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of biologically active peptides: a 'tail' of amino acids can modulate activity of synthetic cyclic peptides.
Bryan A; Joseph L; Bennett JA; Jacobson HI; Andersen TT
Peptides; 2011 Dec; 32(12):2504-10. PubMed ID: 22015269
[TBL] [Abstract][Full Text] [Related]
14. Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein.
Caceres G; Dauphinee MJ; Eisele LE; MacColl R; Mizejewski GJ
Anticancer Res; 2002; 22(5):2817-20. PubMed ID: 12530002
[TBL] [Abstract][Full Text] [Related]
15. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
[TBL] [Abstract][Full Text] [Related]
16. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
17. Biophysical studies and anti-growth activities of a peptide, a certain analog and a fragment peptide derived from alpha-fetoprotein.
Butterstein G; MacColl R; Mizejewski GJ; Eisele LE; Meservey M
J Pept Res; 2003 Apr; 61(4):213-8. PubMed ID: 12605606
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties.
Mansouri W; Fordyce SB; Wu M; Jones D; Cohn D; Lin Q; Feustel P; Sharma T; Bennett JA; Andersen TT
Toxicol Appl Pharmacol; 2018 Apr; 345():10-18. PubMed ID: 29518411
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum alpha fetoprotein levels in postmenopausal women with primary breast carcinoma.
Sarcione EJ; Biddle W
Dis Markers; 1987 Jun; 5(2):75-9. PubMed ID: 2458881
[TBL] [Abstract][Full Text] [Related]
20. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
